TCTR20130520001已完成不适用
A cohort of patients with high risk for cardiovascular events multicenter study .
The Heart Association of Thailand under the Royal Patronage of H.M.0 个研究点目标入组 9,390 人开始时间: 2013年5月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 9,390
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 45 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •Patients who are age at least 45 year old with either high atherosclerotic risk (group 1) or established atherosclerotic cv disease (group 2)
- •Group 1: Patients with The CORE Thailand is conducting to study the risk factors of atherosclerotic risk patients and patients with established atherosclerotic disease (coronary artery disease, cerebrovascular disease and peripheral arterial disease), the cardiovascular event rate in these population, the treatment and investigation for atherosclerotic disease greater than or equal to 3 risk factors as following:
- •1.1 Diabetes (type 1 or 2) or impaired fasting glucose
- •1.2 Hypertension (BP less than140/90 mmHg or currently treated with antihypertensive agent)
- •1.3 Chronic kidney disease stage I-IV
- •1.4 Dyslipidemia
- •1.5 Smoking
- •1.6 Male greater than or equal to 55 year old and woman greater than or equal to 65 year old
- •1.7 family history of premature atherosclerosis
- •Group 2. Patients with established atherosclerotic disease
- •2.1 Patients with cerebrovascular disease: transient ischemic attack, ischemic stroke
- •2.2 Patients with coronary artery disease: stable angina with evidence of myocardial ischemia, acute coronary syndrome, underwent coronary angioplasty/stenting or coronary artery bypass graft, coronary stenosis more than 50 percent by coronary angiogram or coronary CT angiogram
- •2.3 patients with peripheral arterial disease: intermittent claudication with Ankle Brachial Index less than 0.9, intermittent claudication with history of intervention (angioplasty, Vascular bypass graft or amputation)
排除标准
- •1. Patients with recent episodes of acute cariovascular event (within 3 months)
- •2. Patients who are currently in blinded study
- •3. Patients with life expectancy less than 3 years from other illness such as AIDS or cancer
- •4. Patients with surgically indicated aortic aneurysm
- •5. Patients with difficulty of follow up
- •6.Patients who do not give consent
研究者
相似试验
招募中
3 期
ong term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Cardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - DiabetesACTRN12607000333415Consorzio Mario Negri Sud2,100
招募中
不适用
Elucidating the high cardiovascular disease risk in South Asians: focus on monocyte phenotype and incretin hormonesNL-OMON56245Interne Geneeskunde48
招募中
不适用
A study on risk of developing heart disease in patients with skin disease called psoriasis marked by red, itchy, scaly patches.CTRI/2013/08/003928Father Muller Medical College60
尚未招募
Unknown
To Stratify and Identify High Cardiovascular Risk in Rheumatoid Arthritis Patients.CTRI/2024/04/065707Maulana Azad Medical College
已完成
不适用
Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 AgonistsPulmonary Disease, Chronic ObstructiveNCT03405363Boehringer Ingelheim65,406